Journal: Nature Communications
Article Title: Aiolos restricts the generation of antigen-inexperienced, virtual memory CD8 + T cells in mice
doi: 10.1038/s41467-025-67540-8
Figure Lengend Snippet: a Heatmap showing differences in different cytokine receptors between WT and Aiolos-deficient T VM samples. b Schematic of the in vitro treatment of WT and Aiolos-deficient splenic CD8 + T cells, created in Microsoft PowerPoint. Bulk CD8 + T cells were isolated from the spleens of WT and Aiolos-deficient mice and treated with rmIL-12, rmIL-18, and IL-15C (IL-15/IL-15Rα complex) for 30 min (pY-STAT5 and pY-STAT4) or 16 h (IFN-γ, granzyme B and NKG2D) with protein transport inhibitor (PTI) added 4 h prior to harvesting the cells for flow cytometry analysis. Analysis of frequency (%) and median fluorescence intensity (MFI) fold change for ( c ) pY-STAT5 and ( d ) pY-STAT4 between WT and Aiolos-deficient T VM cells, relative to WT. Data representative of 5 independent experiments, n = 5/group, mean ± SEM; two-sided, unpaired Student’s t-test, *p ≤ 0.05 and **p ≤ 0.01. Frequency (%) and MFI fold change for e IFN-γ, f granzyme B, and g NKG2D between WT and Aiolos-deficient T VM cells, relative to WT. Data represents 6 independent experiments, n = 6/group for e , f ; and 5 independent experiments with n = 5/group for NKG2D. Data presented as mean ± SEM; two-sided, unpaired Student’s t-test, *p ≤ 0.05, ***p ≤ 0.001 and ****p ≤ 0.0001. h Percent (%) dead YAC-1 (target) cells when co-cultured with CD8 + T cells in the presence of cytokines (IL-12, Il-18, IL-15C), with or without anti-NKG2D antibody, data from 5 independent experiments with n = 5/condition. Data presented as mean ± SEM; two-way ANOVA with Tukey’s multiple comparisons test *p ≤ 0.05 and ****p ≤ 0.0001. Source data are provided as a file.
Article Snippet: The EL4 murine T cell lymphoma line (TIB-39) for transfection studies and YAC-1 cells (TIB-160) for cytotoxicity were acquired from the American Type Culture Collection (ATCC) and maintained in complete RPMI (RPMI media [catalog # 61870-036, Thermo Fisher Scientific] containing 10% FBS [catalog # 26140-079, Life Technologies] and 1% penicillin/streptomycin [catalog # 15140-122, Life Technologies]).
Techniques: In Vitro, Isolation, Flow Cytometry, Fluorescence, Cell Culture